Search > Results
You searched for: EV210099 (EV-TRACK ID)
Showing 1 - 9 of 9
Showing 1 - 9 of 9
Details | EV-TRACK ID | Experiment nr. | Species | Sample type | Separation protocol | First author | Year | EV-METRIC |
---|---|---|---|---|---|---|---|---|
EV210099 | 1/9 | Homo sapiens | HEK293 T | (d)(U)C | Rider, Mark A | 2016 | 44% | |
Study summaryFull title
All authors
Mark A Rider, Stephanie N Hurwitz, David G Meckes Jr
Journal
Sci Rep
Abstract
Initially thought to be a means for cells to eliminate waste, secreted extracellular vesicles, known (show more...)
EV-METRIC
44% (84th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Cell culture supernatant
Sample origin
Control condition
Focus vesicles
exosome
Separation protocol
Separation protocol
(d)(U)C
Protein markers
EV: CD63/ TSG101/ HSP70/ Alix
non-EV: None Proteomics
no
Show all info
Study aim
New methodological development/Technical analysis comparing/optimizing EV-related methods
Sample
Species
Homo sapiens
Sample Type
Cell culture supernatant
EV-producing cells
HEK293 T
EV-harvesting Medium
EV-depleted medium
Preparation of EDS
>=18h at >= 100,000g
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Below or equal to 800 g
Between 800 g and 10,000 g Between 10,000 g and 50,000 g Between 100,000 g and 150,000 g Pelleting performed
Yes
Pelleting: time(min)
70
Pelleting: rotor type
SW 28
Pelleting: speed (g)
100000
Wash: volume per pellet (ml)
1
Wash: time (min)
70
Wash: Rotor Type
TLA120.2
Wash: speed (g)
100000
Characterization: Protein analysis
Protein Concentration Method
Fluorometric assay (e.g. Qubit, NanoOrange,...)
Western Blot
Antibody details provided?
No
Detected EV-associated proteins
CD63/ TSG101/ HSP70/ Alix
Characterization: RNA analysis
RNA analysis
Type
Capillary electrophoresis (e.g. Bioanalyzer)
Database
No
Proteinase treatment
No
RNAse treatment
No
Characterization: Lipid analysis
No
Characterization: Particle analysis
NTA
Report type
Not Reported
Particle yield
NA NA
EM
EM-type
Transmission-EM
Image type
Close-up
Report size (nm)
Not specified
|
||||||||
EV210099 | 2/9 | Homo sapiens | HEK293 T | DC | Rider, Mark A | 2016 | 38% | |
Study summaryFull title
All authors
Mark A Rider, Stephanie N Hurwitz, David G Meckes Jr
Journal
Sci Rep
Abstract
Initially thought to be a means for cells to eliminate waste, secreted extracellular vesicles, known (show more...)
EV-METRIC
38% (79th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Cell culture supernatant
Sample origin
Control condition
Focus vesicles
exosome
Separation protocol
Separation protocol
DC
Protein markers
EV: CD63/ TSG101/ HSP70/ Alix
non-EV: None Proteomics
no
Show all info
Study aim
New methodological development/Technical analysis comparing/optimizing EV-related methods
Sample
Species
Homo sapiens
Sample Type
Cell culture supernatant
EV-producing cells
HEK293 T
EV-harvesting Medium
EV-depleted medium
Preparation of EDS
>=18h at >= 100,000g
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Below or equal to 800 g
Between 800 g and 10,000 g Between 10,000 g and 50,000 g Pelleting performed
No
Density cushion
Density medium
Sucrose
Sample volume
4
Cushion volume
35
Density of the cushion
30%
Centrifugation time
75
Centrifugation speed
100000
Characterization: Protein analysis
Protein Concentration Method
Fluorometric assay (e.g. Qubit, NanoOrange,...)
Western Blot
Antibody details provided?
No
Detected EV-associated proteins
CD63/ TSG101/ HSP70/ Alix
Characterization: Lipid analysis
No
Characterization: Particle analysis
NTA
Report type
Not Reported
Particle yield
NA NA
EM
EM-type
Transmission-EM
Image type
Close-up
Report size (nm)
Not specified
|
||||||||
EV210099 | 5/9 | Homo sapiens | HEK293 T | NA | Rider, Mark A | 2016 | 38% | |
Study summaryFull title
All authors
Mark A Rider, Stephanie N Hurwitz, David G Meckes Jr
Journal
Sci Rep
Abstract
Initially thought to be a means for cells to eliminate waste, secreted extracellular vesicles, known (show more...)
EV-METRIC
38% (79th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Cell culture supernatant
Sample origin
Control condition
Focus vesicles
exosome
Separation protocol
Separation protocol
NA
Protein markers
EV: CD63/ TSG101/ HSP70/ Alix
non-EV: None Proteomics
yes
Show all info
Study aim
New methodological development/Technical analysis comparing/optimizing EV-related methods
Sample
Species
Homo sapiens
Sample Type
Cell culture supernatant
EV-producing cells
HEK293 T
EV-harvesting Medium
EV-depleted medium
Preparation of EDS
>=18h at >= 100,000g
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Below or equal to 800 g
Pelleting performed
No
Other
Name other separation method
NA
Characterization: Protein analysis
Protein Concentration Method
Fluorometric assay (e.g. Qubit, NanoOrange,...)
Western Blot
Antibody details provided?
No
Detected EV-associated proteins
Alix/ TSG101/ HSC70/ CD63
Proteomics database
No
Characterization: RNA analysis
RNA analysis
Type
Capillary electrophoresis (e.g. Bioanalyzer)
Database
No
Proteinase treatment
No
RNAse treatment
No
Characterization: Lipid analysis
No
Characterization: Particle analysis
NTA
Report type
Not Reported
Particle yield
NA NA
EM
|
||||||||
EV210099 | 3/9 | Homo sapiens | HEK293 T | ExoQuick | Rider, Mark A | 2016 | 25% | |
Study summaryFull title
All authors
Mark A Rider, Stephanie N Hurwitz, David G Meckes Jr
Journal
Sci Rep
Abstract
Initially thought to be a means for cells to eliminate waste, secreted extracellular vesicles, known (show more...)
EV-METRIC
25% (64th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Cell culture supernatant
Sample origin
Control condition
Focus vesicles
exosome
Separation protocol
Separation protocol
ExoQuick
Protein markers
EV: CD63/ TSG101/ HSP70/ Alix
non-EV: None Proteomics
no
Show all info
Study aim
New methodological development/Technical analysis comparing/optimizing EV-related methods
Sample
Species
Homo sapiens
Sample Type
Cell culture supernatant
EV-producing cells
HEK293 T
EV-harvesting Medium
EV-depleted medium
Preparation of EDS
>=18h at >= 100,000g
Separation Method
Commercial kit
ExoQuick
Other
Name other separation method
ExoQuick
Characterization: Protein analysis
Protein Concentration Method
Fluorometric assay (e.g. Qubit, NanoOrange,...)
Western Blot
Antibody details provided?
No
Detected EV-associated proteins
CD63/ TSG101/ HSP70/ Alix
Characterization: Lipid analysis
No
Characterization: Particle analysis
NTA
Report type
Not Reported
Particle yield
NA NA
|
||||||||
EV210099 | 4/9 | Homo sapiens | HEK293 T | Total Exosome Isolation | Rider, Mark A | 2016 | 25% | |
Study summaryFull title
All authors
Mark A Rider, Stephanie N Hurwitz, David G Meckes Jr
Journal
Sci Rep
Abstract
Initially thought to be a means for cells to eliminate waste, secreted extracellular vesicles, known (show more...)
EV-METRIC
25% (64th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Cell culture supernatant
Sample origin
Control condition
Focus vesicles
exosome
Separation protocol
Separation protocol
Total Exosome Isolation
Protein markers
EV: CD63/ TSG101/ HSP70/ Alix
non-EV: None Proteomics
no
Show all info
Study aim
New methodological development/Technical analysis comparing/optimizing EV-related methods
Sample
Species
Homo sapiens
Sample Type
Cell culture supernatant
EV-producing cells
HEK293 T
EV-harvesting Medium
EV-depleted medium
Preparation of EDS
>=18h at >= 100,000g
Separation Method
Commercial kit
Total Exosome Isolation
Other
Name other separation method
Total Exosome Isolation
Characterization: Protein analysis
Protein Concentration Method
Fluorometric assay (e.g. Qubit, NanoOrange,...)
Western Blot
Antibody details provided?
No
Detected EV-associated proteins
CD63/ TSG101/ HSP70/ Alix
Characterization: Lipid analysis
No
Characterization: Particle analysis
NTA
Report type
Not Reported
Particle yield
NA NA
EM
EM-type
Transmission-EM
Image type
Close-up
Report size (nm)
Not specified
|
||||||||
EV210099 | 6/9 | Homo sapiens | Urine | NA | Rider, Mark A | 2016 | 0% | |
Study summaryFull title
All authors
Mark A Rider, Stephanie N Hurwitz, David G Meckes Jr
Journal
Sci Rep
Abstract
Initially thought to be a means for cells to eliminate waste, secreted extracellular vesicles, known (show more...)
EV-METRIC
0% (median: 22% of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Urine
Sample origin
NA
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
NA
Protein markers
EV: None
non-EV: None Proteomics
no
Show all info
Study aim
New methodological development/Technical analysis comparing/optimizing EV-related methods
Sample
Species
Homo sapiens
Sample Type
Urine
EV-harvesting Medium
Control condition
Separation Method
Other
Name other separation method
NA
Protein Concentration Method
Not determined
Characterization: Lipid analysis
No
Characterization: Particle analysis
NTA
Report type
Mean
Reported size (nm)
163.6
EV concentration
Yes
Particle yield
Yes, per milliliter of starting sample 2.42E11
|
||||||||
EV210099 | 7/9 | Homo sapiens | CSF | NA | Rider, Mark A | 2016 | 0% | |
Study summaryFull title
All authors
Mark A Rider, Stephanie N Hurwitz, David G Meckes Jr
Journal
Sci Rep
Abstract
Initially thought to be a means for cells to eliminate waste, secreted extracellular vesicles, known (show more...)
EV-METRIC
0% (median: 12% of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
CSF
Sample origin
NA
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
NA
Protein markers
EV: None
non-EV: None Proteomics
no
Show all info
Study aim
New methodological development/Technical analysis comparing/optimizing EV-related methods
Sample
Species
Homo sapiens
Sample Type
CSF
EV-harvesting Medium
Control condition
Separation Method
Other
Name other separation method
NA
Protein Concentration Method
Not determined
Characterization: Lipid analysis
No
Characterization: Particle analysis
NTA
Report type
Mean
Reported size (nm)
135.4
EV concentration
Yes
Particle yield
Yes, per milliliter of starting sample 0.83E11
|
||||||||
EV210099 | 8/9 | Homo sapiens | Saliva | NA | Rider, Mark A | 2016 | 0% | |
Study summaryFull title
All authors
Mark A Rider, Stephanie N Hurwitz, David G Meckes Jr
Journal
Sci Rep
Abstract
Initially thought to be a means for cells to eliminate waste, secreted extracellular vesicles, known (show more...)
EV-METRIC
0% (median: 25% of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Saliva
Sample origin
NA
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
NA
Protein markers
EV: None
non-EV: None Proteomics
no
Show all info
Study aim
New methodological development/Technical analysis comparing/optimizing EV-related methods
Sample
Species
Homo sapiens
Sample Type
Saliva
EV-harvesting Medium
Control condition
Separation Method
Other
Name other separation method
NA
Protein Concentration Method
Not determined
Characterization: Lipid analysis
No
Characterization: Particle analysis
NTA
Report type
Mean
Reported size (nm)
161.7
EV concentration
Yes
Particle yield
Yes, per milliliter of starting sample 2.41E11
|
||||||||
EV210099 | 9/9 | Mus musculus | Blood plasma | NA | Rider, Mark A | 2016 | 0% | |
Study summaryFull title
All authors
Mark A Rider, Stephanie N Hurwitz, David G Meckes Jr
Journal
Sci Rep
Abstract
Initially thought to be a means for cells to eliminate waste, secreted extracellular vesicles, known (show more...)
EV-METRIC
0% (median: 22% of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Blood plasma
Sample origin
NA
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
NA
Protein markers
EV: None
non-EV: None Proteomics
no
Show all info
Study aim
New methodological development/Technical analysis comparing/optimizing EV-related methods
Sample
Species
Mus musculus
Sample Type
Blood plasma
EV-harvesting Medium
Not specified
Preparation of EDS
Control condition
Separation Method
Other
Name other separation method
NA
Protein Concentration Method
Not determined
Characterization: Lipid analysis
No
Characterization: Particle analysis
NTA
Report type
Mean
Reported size (nm)
120.6
EV concentration
Yes
Particle yield
Yes, per milliliter of starting sample 1.56E11
|
||||||||
1 - 9 of 9 |
EV-TRACK ID | EV210099 | ||||||||
---|---|---|---|---|---|---|---|---|---|
species | Homo sapiens | Homo sapiens | Homo sapiens | Homo sapiens | Homo sapiens | Homo sapiens | Homo sapiens | Homo sapiens | Mus musculus |
sample type | Cell culture | Cell culture | Cell culture | Cell culture | Cell culture | Urine | CSF | Saliva | Blood plasma |
cell type | HEK293 T | HEK293 T | HEK293 T | HEK293 T | HEK293 T | NA | NA | NA | NA |
medium | EV-depleted medium | EV-depleted medium | EV-depleted medium | EV-depleted medium | EV-depleted medium | Control condition | Control condition | Control condition | Not specified |
condition | Control condition | Control condition | Control condition | Control condition | Control condition | NA | NA | NA | NA |
separation protocol | (d)(U)C | DC | NA | ExoQuick | Total Exosome Isolation | NA | NA | NA | NA |
vesicle related term | exosome | exosome | exosome | exosome | exosome | EV | EV | EV | EV |
Exp. nr. | 1 | 2 | 5 | 3 | 4 | 6 | 7 | 8 | 9 |
EV-METRIC % | 44 | 38 | 38 | 25 | 25 | 0 | 0 | 0 | 0 |